Japanese society of pediatric allergy and clinical immunology, Japanese society of allergology. Japanese guidelines for childhood asthma 2017
-
- Arakawa Hirokazu
- Department of Pediatrics, Gunma University Graduate School of Medicine
-
- Hamasaki Yuhei
- Karatsu Medical and Welfare Center for People with Disabilities
-
- Kohno Yoichi
- Chiba Rosai Hospital
-
- Ebisawa Motohiro
- Department of Allergy, Clinical Research Center for Allergology and Rheumatology, National Hospital Organization, Sagamihara National Hospital
-
- Kondo Naomi
- Heisei College of Health Sciences Department of Pediatrics, Graduate School of Medicine, Gifu University
-
- Nishima Sankei
- National Hospital Organization, Fukuoka National Hospital
-
- Nishimuta Toshiyuki
- National Hospital Organization, Shimoshizu National Hospital
-
- Morikawa Akihiro
- Department of Pediatrics, Gunma University Graduate School of Medicine Kita Kanto Allergy Institute
書誌事項
- タイトル別名
-
- Japanese guidelines for childhood asthma 2017
この論文をさがす
抄録
<p>The Japanese Guideline for the Diagnosis and Treatment of Allergic Diseases 2017 (JAGL 2017) includes a minor revision of the Japanese Pediatric Guideline for the Treatment and Management of Asthma 2012 (JPGL 2012) by the Japanese Society of Pediatric Allergy and Clinical Immunology. The section on child asthma in JAGL 2017 provides information on how to diagnose asthma between infancy and adolescence (0–15 years of age). It makes recommendations for best practices in the management of childhood asthma, including management of acute exacerbations and non-pharmacological and pharmacological management. This guideline will be of interest to non-specialist physicians involved in the care of children with asthma. JAGL differs from the Global Initiative for Asthma Guideline in that JAGL emphasizes diagnosis and early intervention of children with asthma at <2 years or 2–5 years of age. The first choice of treatment depends on the severity and frequency of symptoms. Pharmacological management, including step-up or step-down of drugs used for long-term management based on the status of asthma control levels, is easy to understand; thus, this guideline is suitable for the routine medical care of children with asthma. JAGL also recommends using a control test in children, so that the physician aims for complete control by avoiding exacerbating factors and appropriately using anti-inflammatory drugs (for example, inhaled corticosteroids and leukotriene receptor antagonists).</p>
収録刊行物
-
- Allergology International
-
Allergology International 66 (2), 190-204, 2017
一般社団法人日本アレルギー学会
- Tweet
詳細情報
-
- CRID
- 1390001204632021888
-
- NII論文ID
- 130005628188
-
- ISSN
- 14401592
- 13238930
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- Crossref
- CiNii Articles
- KAKEN
-
- 抄録ライセンスフラグ
- 使用不可